BACKGROUND: Few studies exist that evaluate outcomes of pancreatectomy in patients > or =80 y of age, an age group increasing in size in the United States. This study analyzes the outcomes of pancreatectomy in patients > or =80 y of age. METHODS: The medical records of 32 patients > or =80 y of age undergoing pancreatectomy at our institution from April 1995 through October 2008 were reviewed, and outcomes were analyzed. RESULTS: The median patient age was 82 y, and 75% were ASA Class 3. Eighty-one percent of the resections were pancreaticoduodenectomies. There were no operative deaths. Sixty-six percent of patients suffered at least one complication. The median length of stay was 11 d. Eighty-one percent of the resections were performed for cancer. Median survival for all patients was 14.4 mo. Median survival for patients with cancer was 12 mo versus 103 mo for patients without cancer, P = 0.017. CONCLUSIONS: Pancreatectomy in patients > or =80 y of age can be performed with a low risk of mortality but with significant morbidity.
BACKGROUND: Few studies exist that evaluate outcomes of pancreatectomy in patients > or =80 y of age, an age group increasing in size in the United States. This study analyzes the outcomes of pancreatectomy in patients > or =80 y of age. METHODS: The medical records of 32 patients > or =80 y of age undergoing pancreatectomy at our institution from April 1995 through October 2008 were reviewed, and outcomes were analyzed. RESULTS: The median patient age was 82 y, and 75% were ASA Class 3. Eighty-one percent of the resections were pancreaticoduodenectomies. There were no operative deaths. Sixty-six percent of patients suffered at least one complication. The median length of stay was 11 d. Eighty-one percent of the resections were performed for cancer. Median survival for all patients was 14.4 mo. Median survival for patients with cancer was 12 mo versus 103 mo for patients without cancer, P = 0.017. CONCLUSIONS: Pancreatectomy in patients > or =80 y of age can be performed with a low risk of mortality but with significant morbidity.
Authors: Jonathan J Hue; Katherine Bingmer; Kavin Sugumar; Lee M Ocuin; Luke D Rothermel; Jordan M Winter; John B Ammori; Jeffrey M Hardacre Journal: J Gastrointest Surg Date: 2021-02-25 Impact factor: 3.452
Authors: Minna K Lee; Joseph Dinorcia; Patrick L Reavey; Marc M Holden; Jeanine M Genkinger; James A Lee; Beth A Schrope; John A Chabot; John D Allendorf Journal: J Gastrointest Surg Date: 2010-09-08 Impact factor: 3.452
Authors: Saboor Khan; Guido Sclabas; Kaye Reid Lombardo; Michael G Sarr; David Nagorney; Michael L Kendrick; John H Donohue; Florencia G Que; Michael B Farnell Journal: J Gastrointest Surg Date: 2010-08-17 Impact factor: 3.452
Authors: Marcovalerio Melis; Francesca Marcon; Antonio Masi; Antonio Pinna; Umut Sarpel; George Miller; Harvey Moore; Steven Cohen; Russell Berman; H Leon Pachter; Elliot Newman Journal: HPB (Oxford) Date: 2012-05-29 Impact factor: 3.647